{
    "clinical_study": {
        "@rank": "104131", 
        "arm_group": [
            {
                "arm_group_label": "MCT/LCT", 
                "arm_group_type": "Experimental", 
                "description": "Structural Fat Emulsion Injection 250ml per day, for 7 days"
            }, 
            {
                "arm_group_label": "MCT/LCT and fish oil", 
                "arm_group_type": "Experimental", 
                "description": "Structural Fat Emulsion Injection 250ml and  fish oil 100ml for 7 days."
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of this study is to assess the effect of postoperative parenteral fish oil on\n      clinical outcome and immune function after major laparoscopic abdominal surgery."
        }, 
        "brief_title": "Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Gastric Tumor", 
            "Pancreatic Tumor", 
            "Liver Tumor"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Liver Neoplasms", 
                "Stomach Neoplasms", 
                "Pancreatic Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "Postoperative patients are randomized by a sealed envelope to receive either a 50:50\n      (vol/vol) mixture of an oil rich in medium-chain fatty acids and soybean oil (termed\n      MCT/LCT) or a mixture of MCT/LCT and fish oil Omegaven for 7 days. Full blood count,\n      biochemistry and coagulation are routinely assessed. Fresh blood samples are centrifuged\n      into plasma, red blood cells and lymphocytes then stored at \u221280\u00b0C pending analysis.\n\n      The primary endpoint was numbers of infective complications.Secondary endpoints were other\n      clinical outcomes, length of hospital stay, and in-hospital mortality, along with plasma\n      immunological markers."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients undergoing an elective major laparoscopic abdominal surgery and required at\n             least 5 days of parenteral nutrition\n\n        Exclusion Criteria:\n\n          -  Metabolic disease\n\n          -  Chronic kidney or liver failure\n\n          -  Shock\n\n          -  Contraindications for lipid administration\n\n          -  PN during the 15 days before hospitalisation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "15 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01819961", 
            "org_study_id": "Fo-Lap"
        }, 
        "intervention": [
            {
                "arm_group_label": "MCT/LCT and fish oil", 
                "intervention_name": "MCT/LCT and fish oil", 
                "intervention_type": "Drug", 
                "other_name": "Structural Fat Emulsion Injection (Fresenius-Kabi, Germany) and fish oil (Omegaven,Fresenius-Kabi, Germany)"
            }, 
            {
                "arm_group_label": "MCT/LCT", 
                "intervention_name": "MCT/LCT", 
                "intervention_type": "Drug", 
                "other_name": "Structural Fat Emulsion Injection (Fresenius-Kabi, Germany)"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 27, 2013", 
        "location": {
            "contact": {
                "email": "nuzwlvran@yahoo.com.cn", 
                "last_name": "Wei Zhou", 
                "phone": "+86-13588706479"
            }, 
            "facility": {
                "address": {
                    "city": "Hangzhou", 
                    "country": "China", 
                    "state": "Zhejiang", 
                    "zip": "310016"
                }, 
                "name": "Sir Run Run Shaw Hosptial"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Clinical Trial of Omega-3 Fatty Acid-supplemented Parenteral Nutrition Versus Standard Parenteral Nutrition in Patients Undergoing Major Laparoscopic Abdominal Surgery", 
        "overall_contact": {
            "email": "nuzwlvran@yahoo.com.cn", 
            "last_name": "Wei Zhou, MD,  PhD", 
            "phone": "+86-13588706479"
        }, 
        "overall_official": {
            "affiliation": "Sir Run Run Shaw Hospital", 
            "last_name": "Yiping Mou, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "infective complications", 
            "safety_issue": "Yes", 
            "time_frame": "within the first 30 days after surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01819961"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sir Run Run Shaw Hospital", 
            "investigator_full_name": "Wei Zhou", 
            "investigator_title": "Attending", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "length of hospital stay", 
                "safety_issue": "Yes", 
                "time_frame": "average of 2 weeks"
            }, 
            {
                "measure": "plasma immunological markers", 
                "safety_issue": "Yes", 
                "time_frame": "from 1 day before surgery to 7 days after surgery"
            }
        ], 
        "source": "Sir Run Run Shaw Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Wei Zhou", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}